職名 准教授
氏名 いしとび まこと
石飛 真人
生年月  
所属 部局 附属病院
学科・専攻 乳腺センタ-
講座  
教育研究分野 乳癌
TEL  
FAX  
E-mail m-ishitobi@clin.medic.mie-u.ac.jp
個人のホームページ  
学歴 1997年三重大学医学部卒業
学位 2005年大阪大学 乳腺内分泌外科 大学院 修了 医学博士
所属学会 日本外科学会
日本乳癌学会 
日本乳房オンコプラスティックサージェリ―学会
社会活動  
職歴  
学術(芸術)賞 2010年日本乳癌学会研究奨励賞
専門分野 乳癌
現在の研究課題 乳癌
担当科目 乳癌
主な業績等 Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy.
Ishitobi M, Matsuda N, Tazo M, Nakayama S, Tokui R, Ogawa T, Yoshida A, Kojima Y, Kuwayama T, Nakayama T, Yamauchi H, Nakamura S, Tsugawa K, Hayashi N.
Ann Surg Oncol. 2020 Oct 6. doi: 10.1245/s10434-020-09176-0. Online ahead of print.

pTis and pT1a Ipsilateral Breast Tumor Recurrence Is Associated with Good Prognosis after Salvage Surgery.
Ishitobi M, Fukui R, Hashimoto Y, Kittaka N, Nakayama T, Tamaki Y.
Oncology. 2018;94(1):12-18. doi: 10.1159/000480516. Epub 2017 Oct 11.

Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence.
Shien T, Tanaka T, Tanabe M, Okumura Y, Masuda N, Yoshida A, Arima N, Komoike Y, Tanaka S, Iwase T, Taguchi T, Nakatsukasa K, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.
Oncol Lett. 2017 Mar;13(3):1071-1077. doi: 10.3892/ol.2016.5538. Epub 2016 Dec 27.

Local recurrence risk after previous salvage mastectomy.
Tanabe M, Iwase T, Okumura Y, Yoshida A, Masuda N, Nakatsukasa K, Shien T, Tanaka S, Komoike Y, Taguchi T, Arima N, Nishimura R, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.
Eur J Surg Oncol. 2016 Jul;42(7):980-5. doi: 10.1016/j.ejso.2016.03.008. Epub 2016 Mar 26.

Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis.
Yoshida A, Takahashi O, Okumura Y, Arima N, Nakatsukasa K, Tanabe M, Shien T, Masuda N, Tanaka S, Komoike Y, Taguchi T, Iwase T, Nishimura R, Inaji H, Yamauchi H, Ishitobi M; Collaborative Study Group of Scientific Research of Japanese Breast Cancer Society.
Eur J Surg Oncol. 2016 Apr;42(4):474-80. doi: 10.1016/j.ejso.2016.01.011. Epub 2016 Jan 22.

Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence.
Okumura Y, Nishimura R, Nakatsukasa K, Yoshida A, Masuda N, Tanabe M, Shien T, Tanaka S, Arima N, Komoike Y, Taguchi T, Iwase T, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.
Eur J Surg Oncol. 2015 Apr;41(4):548-52. doi: 10.1016/j.ejso.2015.01.030. Epub 2015 Feb 7.

Regional lymphatic recurrence after salvage surgery for ipsilateral breast tumor recurrence of breast cancer without local treatment for regional lymphatic basin.
Ishitobi M, Matsushita A, Nakayama T, Motomura K, Koyama H, Tamaki Y.
J Surg Oncol. 2014 Sep;110(3):265-9. doi: 10.1002/jso.23642. Epub 2014 May 26.

Breast cancer subtype and distant recurrence after ipsilateral breast tumor recurrence.
Ishitobi M, Okumura Y, Arima N, Yoshida A, Nakatsukasa K, Iwase T, Shien T, Masuda N, Tanaka S, Tanabe M, Tanaka T, Komoike Y, Taguchi T, Nishimura R, Inaji H.
Ann Surg Oncol. 2013 Jun;20(6):1886-92. doi: 10.1245/s10434-012-2825-1. Epub 2013 Jan 6.

Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.
Ishitobi M, Ohsumi S, Inaji H, Ohno S, Shigematsu H, Akiyama F, Iwase T, Akashi-Tanaka S, Sato N, Takahashi K, Oura S.
Cancer. 2012 Sep 15;118(18):4385-93. doi: 10.1002/cncr.27377. Epub 2012 Jan 17.

Repeat lumpectomy for ipsilateral breast tumor recurrence after breast-conserving treatment.
Ishitobi M, Komoike Y, Nakahara S, Motomura K, Koyama H, Inaji H.
Oncology. 2011;81(5-6):381-6. doi: 10.1159/000335265. Epub 2012 Jan 20.

Mutational analysis of BARD1 in familial breast cancer patients in Japan.
Ishitobi M, Miyoshi Y, Hasegawa S, Egawa C, Tamaki Y, Monden M, Noguchi S.
Cancer Lett. 2003 Oct 8;200(1):1-7. doi: 10.1016/s0304-3835(03)00387-2.

Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis.
Ishitobi M, Miyoshi Y, Ando A, Hasegawa S, Egawa C, Tamaki Y, Monden M, Noguchi S.
Clin Cancer Res. 2003 Apr;9(4):1376-80.